PHN — Pharmanutra SpA Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapHigh Flyer

Annual income statement for Pharmanutra SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	56.4	68.1	82.7	100	115
Cost of Revenue
Gross Profit	53.7	65.8	79.9	97.8	109
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	43.2	49.4	59.7	76.8	88.1
Operating Profit	13.2	18.7	23	23.4	27.4
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	13.3	18.8	23.4	23.3	27.2
Provision for Income Taxes
Net Income After Taxes	14.1	13.8	15	12.8	16.6
Minority Interest
Net Income Before Extraordinary Items
Net Income	14.1	13.8	15	12.8	16.6
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	14.1	13.8	15	12.8	16.6
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.48	1.42	1.56	1.34	1.75
Dividends per Share